Crescent Capital BDC (CCAP) is a US-listed Financial Services company in Asset Management with a market capitalization of $409M, trading at
1.09 on the NASDAQ. This SniperIQ fundamentals page covers Crescent Capital BDC's valuation (P/E 27.0x, P/B 0.6x), profitability (net margin 12.1%), revenue (
56M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market Cap$409M
P/E (TTM)27.0x
Net Margin12.1%
Revenue (FY25)
56M
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is Crescent Capital BDC's market cap?
Crescent Capital BDC (CCAP) has a market capitalization of approximately $409M, trading at
1.09 on the NASDAQ. Market cap moves with the live share price.
What is Crescent Capital BDC's P/E ratio?
Crescent Capital BDC's trailing twelve-month P/E ratio is 27.0x, with a price-to-book (P/B) of 0.6x. Valuation multiples are best compared with Financial Services sector peers rather than read in isolation.
How profitable is Crescent Capital BDC?
Crescent Capital BDC runs a net profit margin of 12.1%, a gross margin of 66.9%, and an operating margin of 55.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Crescent Capital BDC generate?
Crescent Capital BDC reported revenue of
56M for fiscal year 2025, with net income of
5M and earnings per share (EPS) of 0.93. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Crescent Capital BDC pay a dividend?
Crescent Capital BDC offers a trailing dividend yield of about 15.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Crescent Capital BDC financially healthy?
Crescent Capital BDC carries a debt-to-equity ratio of 1.35x and a current ratio of 0.00x, with a market beta of 0.58. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Crescent Capital BDC a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Crescent Capital BDC (CCAP) the key facts are: market cap $409M, P/E 27.0x, revenue
56M, 52-week range 10.765-16.035. Weigh valuation, profitability, growth, and balance-sheet strength against Financial Services peers and form your own view.
Track Crescent Capital BDC's full fundamentals live
Get Crescent Capital BDC's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.